Key Highlights
- Kimberly-Clark's quarterly Dividend of $1.28 per share trades ex-date September 4, 2026, payable October 2, yielding approximately 4.68%.
- The company completed the sale of its International Family Care and Professional Business on July 1, 2026, for approximately $1.3 billion in cash, retaining a 49% Equity interest in the resulting joint venture.
- Q2 2026 adjusted diluted EPS from continuing operations rose 10.4% to $1.80, even as reported Net Income fell to $345 million from $509 million due to false social-media claims disrupting China diaper sales.
- Kimberly-Clark has paid dividends for 92 consecutive years and increased its dividend for 54 consecutive years.
Kimberly-Clark's (Nasdaq:KMB) quarterly dividend of $1.28 per share yields approximately 4.68%. The more relevant story this quarter is a major portfolio simplification completing just after quarter-end: the $1.3 billion sale of Kimberly-Clark's International Family Care and Professional business closed July 1, even as the company simultaneously worked through a discrete China market disruption that pressured near-term results.
Dividend Program and Shareholder Returns
Kimberly-Clark's Board declared a regular quarterly dividend of $1.28 per share on August 3, 2026, payable October 2, 2026, to stockholders of record September 4, trading ex-dividend the same date and yielding approximately 4.68%. The company has paid a dividend for 92 consecutive years and increased it for 54 consecutive years, having raised the rate from $1.26 to $1.28 in January 2026. The dividend remains central to Kimberly-Clark's capital-allocation framework alongside continued investment, its pending Kenvue acquisition, and share repurchases, with approximately $851 million of dividends declared during the first half of 2026.
About the Company
Kimberly-Clark is a global consumer-products company whose brands include Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, and Pull-Ups, sold in more than 175 countries. The company's portfolio is concentrated in essential personal-care, tissue, and hygiene categories, creating relatively resilient Demand compared with discretionary consumer goods, while the company simultaneously pursues portfolio simplification, supply-chain modernization, and productivity initiatives to strengthen its Margin structure.
Financial Performance Behind the Payout
Kimberly-Clark reported Q2 2026 net sales of $4.189 billion, up 0.6% year over year on continuing operations. Gross Profit rose 10.1% to $1.603 billion, while operating profit increased to $633 million from $592 million, aided by a $45 million refund of previously paid tariffs and strong productivity savings, partially offset by the China social-media disruption and planned investments. Diluted EPS from continuing operations was $1.22, while adjusted diluted EPS from continuing operations rose 10.4% to $1.80. Net income attributable to Kimberly-Clark fell to $345 million from $509 million, with diluted EPS of $1.04, reflecting a net loss from discontinued operations tied to the IFP divestiture accounting.
A Major Divestiture and a China Disruption Arrived in the Same Quarter
The most consequential development for Kimberly-Clark this quarter is the completion of the International Family Care and Professional transaction on July 1, 2026, for approximately $1.3 billion in cash, with the company retaining a 49% equity interest in the joint venture valued at approximately $1.2 billion and expecting to recognize a pre-tax gain of more than $1.0 billion in Q3 2026. This simplification reduces complexity and provides significant cash proceeds just as the company separately navigates a China diaper-market disruption caused by false social-media claims about product quality, which independent government-certified testing has since refuted. The adjusted operating profit metric, up 6.2% versus the prior year, is the more reliable gauge of underlying performance since it strips out the transformation-related charges and Kenvue-related costs embedded in reported operating profit. Investors should watch how quickly the China disruption's sales and profit impact fades and how the IFP proceeds are deployed alongside the pending Kenvue acquisition.
Outlook
Kimberly-Clark's dividend is exceptionally well supported by a 92-year, 54-consecutive-year increase track record and substantial free cash flow, with the IFP divestiture proceeds adding further financial flexibility even as near-term results absorb China-related pressure. Investors should watch the pace of China diaper-sales recovery, integration progress on the pending Kenvue acquisition, deployment of IFP sale proceeds, and continued productivity savings from the 2024 Transformation Initiative.

_09_30_2026_02_08_20_566201.jpg)




Please wait processing your request...